טוען...
The Promise of Chimeric Antigen Receptor (CAR) T Cell Therapy in Multiple Myeloma
A cure for multiple myeloma (MM), a malignancy of plasma cells, remains elusive. Nearly all myeloma patients will eventually relapse and develop resistance to currently available treatments. There is an unmet medical need to develop novel and effective therapies that can induce sustained responses....
שמור ב:
| הוצא לאור ב: | Cell Immunol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6832886/ https://ncbi.nlm.nih.gov/pubmed/31492448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cellimm.2019.103964 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|